Evaluation of the Abbott RealTime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing

Journal of Clinical Virology

Volumn 60, Issue 1, 2014, Pages 22-26

  Mallory, Melanie A ^a   Lucic, Danijela X ^b   Sears, Mitchell T ^a   Cloherty, Gavin A ^b   Hillyard, David R ^a,c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b Abbott Molecular Inc   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

DNA sequencing; Genotyping; Hepatitis C virus; Real time PCR

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; 5' UNTRANSLATED REGION; NS-5 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ANALYZER; ARTICLE; COMPARATIVE STUDY; CROSS REACTION; EVALUATION STUDY; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HEPATITIS C VIRUS GENOTYPE 5; HEPATITIS C VIRUS GENOTYPE 6; HEPATITIS C VIRUS SUBTYPE 1A; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; CLASSIFICATION; DNA SEQUENCE; GENETICS; GENOTYPING TECHNIQUE; HEPACIVIRUS; HEPATITIS C; ISOLATION AND PURIFICATION; LABORATORY AUTOMATION; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

5' UNTRANSLATED REGIONS; AUTOMATION, LABORATORY; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84899075021     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.02.006     Document Type: Article

References (35)

1. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975-982.
2. Ghany M.G., Nelson D.R., Strader D.B., Thomas D.L., Seeff L.B. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American association for the study of liver diseases. Hepatology 2011, 54:1433-1444.
3. Vierling J.M. Hepatitis C virus viral assays in the direct-acting antiviral era. Clin Liver Dis 2013, 17:27-45.
4. Bacon B.R., Gordon S.C., Lawitz E., Marcellin P., Vierling J.M., Zeuzem S., et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011, 364:1207-1217.
5. Poordad F., McCone J., Bacon B.R., Bruno S., Manns M.P., Sulkowski M.S., et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011, 364:1195-1206.
6. Jacobson I.M., McHutchison J.G., Dusheiko G., Di Bisceglie A.M., Reddy K.R., Bzowej N.H., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011, 364:2405-2416.
7. Zeuzem S., Andreone P., Pol S., Lawitz E., Diago M., Roberts S., et al. Telaprevir for retreatment of HCV infection. N Engl J Med 2011, 364:2417-2428.
8. Simmonds P., Smith D.B., McOmish F., Yap P.L., Kolberg J., Urdea M.S., et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994, 75:1053-1061.
9. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
10. Hraber P.T., Fischer W., Bruno W.J., Leitner T., Kuiken C. Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: the 5' untranslated region (UTR) fails to classify subtypes. Virol J 2006, 3:103.
11. Murphy D.G., Willems B., Deschênes M., Hilzenrat N., Mousseau R., Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol 2007, 45:1102-1112.
12. Martro E., Gonzalez V., Buckton A.J., Saludes V., Fernandez G., Matas L., et al. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions. J Clin Microbiol 2008, 46:192-197.
13. Cento V., Landonio S., De Luca F., Di Maio V.C., Micheli V., Mirabelli C., et al. A boceprevir failure in a patient infected with HCV-genotype 1g: importance and limitations of virus genotyping prior to HCV protease inhibitor-based therapy. Antivir Ther (Lond) 2013, 18:645-648.
14. Molenkamp R., Harbers G., Schinkel J., Melchers W.J.G. Identification of two hepatitis C virus isolates that failed genotyping by versant LiPA 2. 0 assay 2009, 44:250-253.
15. Bouchardeau F., Cantaloube J.F., Chevaliez S., Portal C., Razer A., Lefrere J-J., et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007, 45:1140-1145.
16. Verbeeck J., Stanley M.J., Shieh J., Celis L., Huyck E., Wollants E., et al. Evaluation of versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol 2008, 46:1901-1906.
17. Chevaliez S., Bouvier-Alias M., Brillet R., Pawlotsky J.-M., Hepatitis C. Virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS ONE 2009, 4:e8209.
18. Kuiken C., Simmonds P. Nomenclature and numbering of the hepatitis C virus. Hepatitis C 2009, 33-53. Humana Press. H. Tang (Ed.).
19. Sohn Y.-H., Ko S.-Y., Kim M.H., Oh H.-B. Performance evaluation of the Abbott RealTime HCV genotype II for hepatitis C virus genotyping. Clin Chem Lab Med 2010, 48:469-474.
20. Shinol R.C., Gale H.B., Kan V.L. Performance of the Abbott RealTime HCV genotype II RUO assay. J Clin Microbiol 2012, 50:3099-3101.
21. González V., Gomes-Fernandes M., Bascuñana E., Casanovas S., Saludes V., Jordana-Lluch E., et al. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J Clin Virol 2013, 58:249-253.
22. Ciotti M., Marcuccilli F., Guenci T., Babakir-Mina M., Chiodo F., Favarato M., et al. A multicenter evaluation of the Abbott RealTime HCV Genotype II assay. J Virol Methods 2010, 167:205-207.
23. Hong S.K., Cho S.I., Ra E.K., Kim E.-C., Park J.S., Park S.S., et al. Evaluation of two hepatitis C virus genotyping assays based on the 5' untranslated region (UTR): the limitations of 5' UTR-based assays and the need for a supplementary sequencing-based approach. J Clin Microbiol 2012, 50:3741-3743.
24. Germer J.J., Rys P.N., Thorvilson J.N., Persing D.H. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the amplicor HCV test. J Clin Microbiol 1999, 37:2625-2630.
25. Okamoto H., Tokita H., Sakamoto M., Horikita M., Kojima M., Iizuka H., et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993, 74:2385-2390.
26. Laperche S., Lunel F., Izopet J., Alain S., Dény P., Duverlie G., et al. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005, 43:733-739.
27. Swofford D. PAUP*: Phylogenetic Analysis using Parsimony, Version 4.0b10 2003.
28. Larrat S., Poveda J.-D., Coudret C., Fusillier K., Magnat N., Signori-Schmuck A., et al. Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2. 0. J Clin Microbiol 2013, 51:2815-2821.
29. Ghany M.G., Strader D.B., Thomas D.L., Seeff L.B. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009, 49:1335-1374.
30. Eineichner T.K., Germer J.J., Bommersbach C.E., Mitchell P.S., Yao J.D.C. Abbott RealTime HCV genotype II assay: reliability and accuracy. 28th Annual Clinical Virology Symposium, Daytona Beach, FL, USA 2012.
31. Pollicita M., Cento V., Paba P., Perno C.F., Ciotti M. Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype. J Virol Methods 2013, 193:205-208.
32. Noppornpanth S., Sablon E., De Nys K., Lien T.X., Brouwer J., Van Brussel M., et al. Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5' untranslated regions. J Clin Microbiol 2006, 44:3969-3974.
33. Nadarajah R., Khan G., Miller S., Brooks G. Evaluation of a new-generation line-probe assay that detects 5' untranslated and core regions to genotype and subtype hepatitis C virus. Am J Clin Pathol 2007, 128:300-304.
34. Cai Q., Zhao Z., Liu Y., Shao X., Gao Z. Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int J Mol Med 2013, 31:347-352.
35. Morel V., Fournier C., François C., Brochot E., Helle F., Duverlie G., et al. Genetic recombination of the hepatitis C virus: clinical implications: impacts of HCV recombination. J Viral Hepatitis 2011, 18:77-83.